Refractory Plasma Cell Myeloma Clinical Trials in Atlanta

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • New Haven, Connecticut
  • +8 more
2022-03-29
Mar 29, 2022
E
Active, not recruiting
  • ISS Stage I Plasma Cell Myeloma
  • +4 more
  • Pembrolizumab
  • Radiation Therapy
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
2022-03-02
Mar 2, 2022
N
Active, not recruiting
  • DS Stage I Plasma Cell Myeloma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Scottsdale, Arizona
  • +139 more
2022-02-09
Feb 9, 2022
E
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
2022-01-05
Jan 5, 2022
C
Active, not recruiting
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
2021-08-18
Aug 18, 2021
F
Completed
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
2019-10-29
Oct 29, 2019
N
Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Tampa, Florida
  • +8 more
2015-07-24
Jul 24, 2015